Comment: Prolific year bodes well for 2016
Macro concerns including the Chinese economic slowdown and further conflict in the Middle East have not dented investor optimism for 2016, says Mo Merali
More on Performance
Unquote Private Equity Podcast: Nordic 2020 Review
Katharine Hidalgo welcomes Unquote Nordic reporter Eliza Punshi to discuss how dealflow and fundraising prospects are faring as 2021 rolls on
Unquote Private Equity Podcast: DACH 2020 Review
Katharine Hidalgo welcomes Unquote DACH reporter Harriet Matthews to discuss how dealflow and fundraising prospects are faring as 2021 rolls on
Unquote Private Equity Podcast: UK & Ireland 2020 Review
Early figures highlight how a 2008-style meltdown was averted in 2020, both in terms of deal-doing and fundraising
Unquote Private Equity Podcast: Southern Europe 2020 Review
National coronavirus restrictions threatened to scupper the PE industry across Europe in the spring, but investors adapted swiftly
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018